NASDAQ:DSGN

Design Therapeutics Stock Forecast

etoro logo Buy DSGN
*Your capital is at risk
$12.44
+0.510 (+4.27%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of DSGN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DSGN to Watchlist?
Some Reasons Why To Add DSGN:
  • +232.6% price growth over the last year
  • Low bankruptcy risk (Altman Z-Score: 30.65)
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Green day on Thursday for Design Therapeutics, Inc. stock after gaining 4.27%
(Updated on Jun 18, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 15, 2026 Gain 11.67%

The Design Therapeutics, Inc. stock price gained 4.27% on the last trading day (Thursday, 18th Jun 2026), rising from $11.93 to $12.44. During the last trading day the stock fluctuated 6.24% from a day low at $11.94 to a day high of $12.68. The price has risen in 6 of the last 10 days and is up by 15.61% over the past 2 weeks. Volume fell on the last day by -51 thousand shares and in total, 926 thousand shares were bought and sold for approximately $11.52 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.25% during the next 3 months and, with a 90% probability hold a price between $9.87 and $15.29 at the end of this 3-month period.

DSGN Signals & Forecast

Mostly positive signals in the chart today. The Design Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $11.20 and $12.06. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 22.32%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Design Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $11.10 and $10.70. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Design Therapeutics, Inc. finds support just below today's level at $11.10. If this is broken, then the next support from accumulated volume will be at $10.70 and $10.49.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.745 between high and low, or 6.24%. For the last week, the stock has had daily average volatility of 6.80%.

Our recommended stop-loss: $12.06 (-3.04%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (DSGN) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Design Therapeutics, Inc. to open at $12.35, and during the day (based on 14 day Average True Range), to move between $12.03 and $12.85, which gives a possible trading interval of +/-$0.83 (+/-6.88%) up or down from last closing price. If Design Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $12.53 (0.72%) than the support at $11.10 (10.77%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Design Therapeutics, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 4.822 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $12.35 ( 0.710%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DSGN Performance

Trading levels for DSGN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 13.10 5.28%
R2 12.81 2.99%
R1 12.64 1.58%
Price 12.44
S1 12.07 -3.00%
S2 11.89 -4.41%
S3 11.61 -6.70%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.55 16.96%
R2 13.60 9.32%
R1 12.53 0.723%
Price 12.44
S1 11.10 -10.77%
S2 10.70 -13.99%
S3 10.49 -15.68%

FAQ

What is the symbol for Design Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Design Therapeutics, Inc. is DSGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Design Therapeutics, Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Design Therapeutics, Inc. Stock?
Design Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Design Therapeutics, Inc. Stock.

What's the current price of Design Therapeutics, Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Design Therapeutics, Inc. (DSGN) share was $12.44.

What is the 52-week high and low for Design Therapeutics, Inc. Stock?
The 52-week high for Design Therapeutics, Inc. Stock is $17.25 and the 52-week low is $3.33.

What is the market capitalization of Design Therapeutics, Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Design Therapeutics, Inc. is 776.965M.

When is the next earnings date for Design Therapeutics, Inc.?
The upcoming earnings date for Design Therapeutics, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT DESIGN THERAPEUTICS, INC.
Design Therapeutics
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysf...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE